Cell line name |
HCI-EC-23 |
Synonyms |
Huntsman Cancer Institute-Endometrial cancer-23 |
Accession |
CVCL_E3GB |
Resource Identification Initiative |
To cite this cell line use: HCI-EC-23 (RRID:CVCL_E3GB) |
Comments |
Characteristics: Retains ER expression and hormonal responsiveness (PubMed=36396974). Characteristics: Established from a mouse xenograft (EC-PDX-23) (PubMed=36396974). Doubling time: ~30 hours (PubMed=36396974). Microsatellite instability: Instable (MSI-high) (PubMed=36396974). Omics: Genomics; ChIP-seq; H3K27ac. Omics: Genomics; Whole exome sequencing. Omics: Transcriptomics; RNAseq. Derived from site: In situ; Endometrium; UBERON=UBERON_0001295. |
Sequence variations |
- Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Gly801Valfs*32 (c.2402delG); Zygosity=Unspecified (PubMed=36396974).
- Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Gln2070Ter (c.6208C>T); Zygosity=Unspecified (PubMed=36396974).
- Mutation; HGNC; HGNC:15840; KMT2B; Simple; p.Gly1733Trpfs*6 (c.5196dupT); Zygosity=Unspecified (PubMed=36396974).
- Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Ser4327Glnfs*7 (c.12978dupG); Zygosity=Unspecified (PubMed=36396974).
- Mutation; HGNC; HGNC:14234; NSD1; Simple; p.Met1531Cysfs*43 (c.4591delA); Zygosity=Unspecified (PubMed=36396974).
- Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu39Lys (c.115G>A); ClinVar=VCV003258061; Zygosity=Unspecified (PubMed=36396974).
- Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg93Gln (c.278G>A); ClinVar=VCV000419128; Zygosity=Unspecified (PubMed=36396974).
- Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg130Gly (c.388C>G); ClinVar=VCV000375958; Zygosity=Unspecified (PubMed=36396974).
- Mutation; HGNC; HGNC:777; ZFHX3; Simple; p.Arg2693Ter (c.8077C>T); Zygosity=Unspecified (PubMed=36396974).
|
Disease |
Type I endometrial adenocarcinoma (NCIt: C40145) |
Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
Sex of cell |
Female |
Age at sampling |
66Y |
Category |
Cancer cell line |
STR profile |
Source(s): Millipore=SCC641
Markers:Amelogenin | X |
CSF1PO | 12,13 |
D3S1358 | 16,17 |
D5S818 | 11 |
D7S820 | 10,11 |
D8S1179 | 12,13,14 |
D13S317 | 11,12 |
D16S539 | 11,12 |
D18S51 | 12,15 |
D21S11 | 28,29 |
FGA | 20,24,25 |
Penta D | 11,12 |
Penta E | 12,15 |
TH01 | 9.3,10 |
TPOX | 8,9 |
vWA | 17,19,20 |
Run an STR similarity search on this cell line |
Publications | PubMed=36396974; DOI=10.1038/s41598-022-24211-8; PMCID=PMC9672046 Rush C.M., Blanchard Z., Polaski J.T., Osborne K.S., Osby K., Vahrenkamp J.M., Yang C.-H., Lum D.H., Hagan C.R., Leslie K.K., Pufall M.A., Thiel K.W., Gertz J. Characterization of HCI-EC-23 a novel estrogen- and progesterone-responsive endometrial cancer cell line. Sci. Rep. 12:19731.1-19731.17(2022) |
Cross-references |
Cell line collections (Providers) |
Millipore; SCC641
|
Gene expression databases |
GEO; GSM6421755
GEO; GSM6421756
GEO; GSM6421757
GEO; GSM6421761
GEO; GSM6421762
GEO; GSM6421763
GEO; GSM6421764
GEO; GSM6421765
GEO; GSM6421766
GEO; GSM6421767
GEO; GSM6421768
GEO; GSM6727284
GEO; GSM6727285
|
Entry history |
Entry creation | 19-Dec-2024 |
Last entry update | 10-Apr-2025 |
Version number | 2 |
---|